FDA Clearance Tracker · K181790
CLUNGENE Multi-Drug Test Dip Card, CLUNGENE Multi-Drug Test Easy Cup
Last checked: Nov 19, 2026Latest source record: Jul 26, 2018 (this decision)Source: openFDAMethods & limitations
Decided
Jul 26, 2018
Substantially Equivalent
Time to decision
21 days
Received Jul 5, 2018. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K181790
- Device name
- CLUNGENE Multi-Drug Test Dip Card, CLUNGENE Multi-Drug Test Easy Cup
- Applicant
- Hangzhou Clongene Biotech Co., Ltd.
- Applicant location
- Hangzhou, CN
- Received
- Jul 5, 2018
- Decided
- Jul 26, 2018
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device type
- Test, Opiates, Over The Counter (NGL)
- Device class
- Class II
- Regulation
- 21 CFR 862.3650
- Specialty
- Laboratory Medicine & Pathology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code NGL. The earliest in FDA's data is K082898, decided Dec 19, 2008.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K181790
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Hangzhou Clongene Biotech Co., Ltd.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K253318 · Decided Jan 30, 2026 · 122 days after receipt
Device type: Antigen, Cf (Including Cf Controls), Respiratory Syncytial Virus (GQG) · Laboratory Medicine & Pathology
K252118 · Decided Aug 27, 2025 · 51 days after receipt
Device type: Test, Amphetamine, Over The Counter (NFT) · Laboratory Medicine & Pathology
K242802 · Decided Nov 8, 2024 · 52 days after receipt
Device type: Test, Opiates, Over The Counter (NGL) · Laboratory Medicine & Pathology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.